PLERIXAFOR
PLERIXAFOR injection, for subcutaneous use
Approved
Approval ID
43df348a-d7f2-4f14-8131-c916679a98eb
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 28, 2023
Manufacturers
FDA
Zydus Lifesciences Limited
DUNS: 918596198
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
plerixafor
PRODUCT DETAILS
NDC Product Code70771-1776
Application NumberANDA208980
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateJuly 28, 2023
Generic Nameplerixafor
INGREDIENTS (5)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PLERIXAFORActive
Quantity: 24 mg in 1.2 mL
Code: S915P5499N
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 5.9 mg in 1.2 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT